期刊文献+

慢性丙型肝炎患者干扰素治疗前后血清细胞因子变化的研究 被引量:2

Study on the changes of serum cytokines in patients with chronic hepatitis C before and after IFN treatment
下载PDF
导出
摘要 目的:观察慢性丙型肝炎患者干扰素治疗前后白细胞介素-18(IL-18)、白细胞介素-10(IL-10)、肿瘤坏死因子-α(TNF-α)水平的变化,探讨它们在慢性丙型肝炎发病中的作用。方法:酶联免疫吸附(ELISA)法检测15例正常人、30例丙型肝炎病毒携带者及30例慢性丙型肝炎患者(包括干扰素治疗前、后)血清中细胞因子水平。结果:慢性丙型肝炎患者血清中上述细胞因子显著高于正常对照组(P<0.05)及丙型肝炎病毒携带者组(P<0.05),其值与谷丙转氨酶(GPT)呈显著正相关;经干扰素治疗后上述细胞因子水平均明显降低(P<0.05),IFN抗病毒治疗前血清中IL-10水平由高到低依次为无应答组>部分应答组>完全应答组。结论:上述细胞因子共同参与慢性丙型肝炎的发病过程,并可用于评价干扰素对于机体免疫状态的影响;其中血清中IL-10水平对预测抗病毒疗效有重要意义。 Objective:To observe the changes of serum levels of IL-18,IL-10 and TNF-αin the patients with chronic hepatitis C before and after IFN treatment and to discuss the roles of the above- mentioned serum cytokines in the pathogenisis of chronic hepatitis C.Methods:To detect the levels of IL-18,IL-10 and TNF-α in 15 healthy controls, 30 asymptomatic HCV carriers and 30 patients with chronic hepatitis C ( before and after IFN treatment )by enzyme linked immunosorbent assay (ELISA).Results:The levels of IL-18,IL-10 and TNF-α in the patients with chronic hepatitis C were higher than those in healthy controls(P<0.05) and in asymptomatic HCV carriers(P<0.05).The valus of the above-mentioned cytokines showed a significant positive correlation to GPT.The levels of above-mentioned cytokines decreased obviously after IFN treatment(P<0.05),while the serum levels of IL-10 reduced in sequence in no-response group,partial-response group and complete-response group.Conclusion:IL-18,IL-10 and TNF-αco-participate in the pathogenisis of chronic hepatitis C,and are probably used to evaluate the effect of IFN on the immunical state of patients,and IL-10 is important for predicting the anti-viral efficacy of IFN.
出处 《现代医药卫生》 2006年第19期2919-2921,共3页 Journal of Modern Medicine & Health
关键词 慢性丙型肝炎 干扰素 IL-18 IL-10 TNF-α Chronic hepatitis C IFN IL-18 IL-10 TNF-α
  • 相关文献

参考文献11

  • 1[1]Gramenzi A,Andreone P,Loggi E,et al.Cytokine profile of peripheral blood mononuclear cells from patients with different outcomes of hepatitis C virus infection[J].J Viral Hepat,2005,12(5):525. 被引量:1
  • 2[2]Graham CS,Wells A,Liu T,et al.Relationships between cellular immune responses and treatment outcomes with interferon and ribavirin in HIV-/hepatitis C virus co-infection[J].AIDS,2006,20(3):345. 被引量:1
  • 3[3]Zeuzem S,Hopf U,Carreno V,et al.A phase Ⅰ/Ⅱ study of recombinant human interleukin-12 in patients with chronic hepatitis C[J].Hepatology,1999,29(4):1280. 被引量:1
  • 4[4]Asakawa M,Kono H,Amemiya H,et al.Role of interleukin-18 and its receptor in hepatocellular carcinoma associated with hepatitis C virus infection[J].Int J Cancer,2006,118(3):564. 被引量:1
  • 5[5]Vecchiet J,Falasca K,Cacciatore P,et al.Association between plasma interleukin-18 levels and liver injury in chronic hepatitis C virus infection and non-alcoholic fatty liver disease[J].Ann Clin Lab Sci,2005,35(4):415. 被引量:1
  • 6[6]Tsai SL,Liaw YF,Chem MH,et al.Detection of type 2 like T-helper cells in hepatitis C virus infection:implications for hepatitis viruus chronicity[J].Hepatology,1997,25:449. 被引量:1
  • 7[7]Murata K,Yamamoto N,Kawakita T,et al.Up-regulation of IL-18 by interferon alpha-2b/ribavirin combination therapy induces an anti-viral effect in patients with chronic hepatitis C[J].Hepatogastroenterology,2005,52(62):547. 被引量:1
  • 8[8]Schvoerer E,Navas MC,Thumann C,et al.Production of interleukin-18and interleukin-12 in patients suffering from chronic hepatitis C virus infection before antivird therapy[J].J Med Virol,2003,70(4):588. 被引量:1
  • 9[9]Yao HP,Xia DJ,Zhang LH,et al.Serum levels of sFas,sICAM-1,IL-18in patients with chronic hepatitis C and their clinical significance[J].Zhejiang Da Xue Xue Bao Yi Xue Ban,2002,31(1):2. 被引量:1
  • 10[10]Cacciarelli TV,Martinez OM,Gish RG,et al.Immunoregulatory cytokines in chronic hepatitis C virus infection:pre-and post treatment with interferon alpha[J].Hepatology,1996,24:6. 被引量:1

同被引文献10

  • 1曾宏,刘集鸿,周华坚.慢性丙型肝炎患者抗病毒治疗前后血清IL-18、IL-10及sFas水平变化与意义[J].现代医药卫生,2006,22(11):1602-1603. 被引量:2
  • 2Durmanova V, Sapak M, Kosovsky J, et al. Immune response and cytokine production following immunization with experimental herpes simplex virus 1 (HSV- 1 ) vaccines. Folia Microbiol (Praha) 2008,53(1) :73 - 83. 被引量:1
  • 3Sansonno D, Lacobelli AR, Comacchiulo V, et al. Detection of heptits C virus (HCV) protein by immunofluorence and HCV RNA genomic sequence by non-isotopic in situ hybridization in bone marrow and PBMCs or chronically HCV- infected patients [J]. Clin Exp Immunol, 1996,103(3) : 414-421. 被引量:1
  • 4Murata K, Yamamoto N, Kawakita T, et al. Up-regulation of IL-18 by interferon alpha-2b/ ribavirin combination therapy induees an anti-viral effeet in patients with chronic hepatitis C [ J ]. Hepatogustroenterology, 2005,52 (62) : 547-551. 被引量:1
  • 5Schvoerer E, Navas MC, Thumann C, et al. Production of inerleukin-18 and inerleukin-12 in patients suffering from chronic hepatitis C virus infection before antiviral therapy [J]. Med Virol, 2003,70(4) :588-593. 被引量:1
  • 6Graham CS, Wells A, Liu T, et al. Relationships between cellular immune responses and treatment outcomes with interferon and ribavirin in HIV/hepatitis C virus co-infectian [J]. AIDS, 2006,20(3) :345-351. 被引量:1
  • 7Asakawa M, Kono H, Amemiya H, et al. Role of interleukin-18 and its receptor in hepatocellular carcinoma associated with hepatitis C virus infection [J]. Int J Cancer, 2006, 118(3) :564-570. 被引量:1
  • 8王长娴,张建琼.干扰素治疗丙型肝炎疗效的预测指标[J].国外医学(病毒学分册),2000,7(4):103-107. 被引量:9
  • 9张道杰,段朝霞.IL-10的研究进展[J].国外医学(免疫学分册),2003,26(1):39-41. 被引量:45
  • 10刘文春,黄星源.白细胞介素18及其抗感染作用研究进展[J].国外医学(儿科学分册),2003,30(5):248-250. 被引量:2

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部